Your email has been successfully added to our mailing list.

×
0 0 0.0165745856353591 0.0276243093922652 0.0276243093922652 -0.0220994475138122 0 -0.0276243093922652
Stock impact report

NewLink Genetics Presents Updated NLG802 Results at the Immuno-Oncology 2019 World Congress

NEWLINK GENETICS (NLNK) 
Last newlink genetics earnings: 2/28 09:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.linkp.com/investor-relations
Company Research Source: GlobeNewswire
NLG802, a prodrug of indoximod, produced significantly higher pharmacokinetic (PK) exposure in patients compared to molar equivalent of indoximod while maintaining encouraging safety profileNotable response in 5th line pancreatic cancer patient re-challenged with chemotherapy after NLG802 treatment ended AMES, Iowa, May 23, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced the abstract (Poster 61) entitled, “A Phase 1 Clinical Trial of NLG802, a Prodrug of Indoximod with Enhanced Pharmacokinetic Properties,” was presented at the Immuno-Oncology 2019 2nd World Congress in Barcelona, Spain. The Phase 1 dose-escalation study evaluated the safety, toxicity and PK of NLG802 to determine the maximum tolerated dose (MTD) or maximum biologically achievable dose (MBAD).  Data from the study was used to recommend a Phase 2 dose (RP2D) of NLG802. NLG802 was administered orally at five dose levels up to 1452 mg BID in 26 patients with recurrent advanced sol Show less Read more
Impact Snapshot
Event Time:
NLNK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NLNK alerts
Opt-in for
NLNK alerts

from News Quantified
Opt-in for
NLNK alerts

from News Quantified